Clinical guidance and expert opinion on the use of prostatic urethral lift implants for benign prostatic hyperplasia
Abstract
ABSTRACT Introduction Minimally invasive surgical therapies (MISTs) for benign prostatic hyperplasia (BPH) are increasingly favored for their efficacy in symptom relief and reduced morbidity. Prostatic urethral lift has gained traction in the last decade due to its non-ablative properties and favorable clinical outcomes. Areas covered In this article, we provide a narrative review including articles prior to July 2026 focusing on prostatic urethral lift technology. We provide a brief technical overview of the implant and implantation process, outlining key differences in the first- and second-generation systems. We provide clinical evidence demonstrating its safety and efficacy in relieving prostate symptoms, reviewing some of the pivotal and recent trials in men with classical BPH and those with median lobe enlargement. Expert opinion Prostatic urethral lift offers patients a unique intermediate option between medical and ablative surgical management. It is particularly well-suited for younger men with a prostate volume of 30–80 cc, especially for those whom preservation of sexual and erectile function is a priority or who are not prepared for the morbidity associated with other surgical therapies. Its simplicity and ability to be performed under local anesthetic allow it to be adapted to an outpatient setting.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.